Thus, with nonclassical monocyte deficiency in the setting of lung cancer, there was selective reduction in CD8+ T cell activation and effector phenotype in tumor-draining lymph nodes in response to tumor that was not observed in CD4+ T cells. This evidence concerns the gene CD4 and lung cancer.